We specialise in generating alternative returns for our clients in easy-to-access portfolios.
WHO WE ARE
Established in 1999, Oxford Capital is an alternative investment manager passionate about investing in early stage technology companies. For over 20 years, we have offered private investors and family offices access to some of the most impactful technology companies in sectors which the UK is considered a world leader.
We partner with portfolio companies and founders to grow their businesses and deliver meaningful impact in their fields. Based in Oxford and London, we are at the heart of Europe’s most exciting technology clusters.
WHAT WE DO
We invest our clients’ funds in unquoted UK companies in a range of strategies, available in both tax-efficient portfolios and for direct investment.
Ventures strategy: investing in leading early stage tech-driven companies
Venture Capital investments into early-stage technology companies have been at the heart of our business since we launched our first fund in 1999. Over the years we have helped many young companies to win in international markets. Our investment team has more than 50 years of investment experience. They back entrepreneurs who are aiming to solve big problems in innovative ways. Click here to visit our Ventures strategy.
Media strategy: investing in the UK’s creative industries
We also invest into the UK’s thriving media sector, with a current focus on independent films. Click here to visit our Media strategy.
The capital we invest is raised from private individuals, family offices, endowments, pension funds and other institutional investors. Their investments have helped to create employment, to generate exports and to foster innovation. They have enabled companies to generate new products and services and open up new markets, improve the environment and enhance healthcare.
We are continually on the look-out for new investment ideas. We strive to evolve our organisation to capture opportunities and expand for the benefit of our investors, entrepreneurs and colleagues.